WallStreetZenWallStreetZen

NASDAQ: ABCL
Abcellera Biologics Inc Stock Ownership - Who owns Abcellera Biologics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Abcellera Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thermopylae Holdings Ltd10% Owner2025-03-11343,631$2.16
$742.24kBuy
John S. MontalbanoDirector2025-03-1025,000$2.30
$57.50kBuy
John S. MontalbanoDirector2025-03-0660,000$2.34
$140.58kBuy
Carl L. G. HansenChief Executive Officer2024-11-2556,125$2.70
$151.54kBuy
Carl L. G. HansenChief Executive Officer2024-09-2056,125$2.70
$151.54kBuy
Thermopylae Holdings Ltd10% Owner2024-08-29283,516$2.61
$739.98kBuy
Veronique LecaultChief Operating Officer2024-06-2183,334$0.19
$15.67kBuy
Carl L. G. HansenChief Executive Officer2024-05-3156,125$2.70
$151.54kBuy

1 of 1

ABCL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABCL insiders and whales buy or sell their stock.

ABCL Shareholders

What type of owners hold Abcellera Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Carl L. G. Hansen19.12%56,984,009$137.90MInsider
Thermopylae Holdings Ltd18.84%56,143,640$135.87MInsider
Baker Bros Advisors LP9.24%27,525,640$66.61MInstitution
John Hamer4.94%14,734,623$35.66MInsider
Baillie Gifford Co4.11%12,236,465$29.61MInstitution
Voya Investment Management LLC3.57%10,624,185$25.71MInstitution
Capital World Investors2.66%7,933,613$19.20MInstitution
Prosight Management LP2.47%7,350,000$17.79MInstitution
Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC1.51%4,500,000$10.89MInstitution
Orbimed Advisors LLC1.40%4,180,768$10.12MInstitution

1 of 3

ABCL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABCL38.22%44.73%Net BuyingNet Buying
DAWN59.43%40.57%Net SellingNet Selling
CVAC3.50%0.00%
QURE76.94%12.75%Net SellingNet Selling
AVXL34.70%5.13%Net BuyingNet Buying
View Top Biotech Stocks

Abcellera Biologics Stock Ownership FAQ

Who owns Abcellera Biologics?

Abcellera Biologics (NASDAQ: ABCL) is owned by 38.22% institutional shareholders, 44.73% Abcellera Biologics insiders, and 17.06% retail investors. Carl L. G. Hansen is the largest individual Abcellera Biologics shareholder, owning 56.98M shares representing 19.12% of the company. Carl L. G. Hansen's Abcellera Biologics shares are currently valued at $139.61M.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.